Emrah ERASLAN, Ayşegül İLHAN, Fatih YILDIZ, Mutlu DOĞAN

First-line palliative chemotherapy clinical benefit is a key determinant of survival in metastatic uterine leiomyosarcoma

Journal of Health Sciences and Medicine

2021-Cilt: 4 - Sayı: 6

795-799

Metastatic uterine leiomyosarcoma, Palliative chemotherapy, Clinical benefit, Overall survival

78 102